X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Fresenius Kabi Onco. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs FRESENIUS KABI ONCO. - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS FRESENIUS KABI ONCO. J.B.CHEMICALS/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 14.0 22.1 63.1% View Chart
P/BV x 2.2 3.1 70.9% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 J.B.CHEMICALS   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
FRESENIUS KABI ONCO.
Mar-13
J.B.CHEMICALS/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs318176 180.7%   
Low Rs20079 254.1%   
Sales per share (Unadj.) Rs148.037.7 392.7%  
Earnings per share (Unadj.) Rs19.15.1 374.7%  
Cash flow per share (Unadj.) Rs23.96.7 356.2%  
Dividends per share (Unadj.) Rs0.500-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs128.942.5 303.1%  
Shares outstanding (eoy) m84.82158.23 53.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.73.4 51.8%   
Avg P/E ratio x13.625.0 54.3%  
P/CF ratio (eoy) x10.818.9 57.1%  
Price / Book Value ratio x2.03.0 67.1%  
Dividend payout %2.60-   
Avg Mkt Cap Rs m21,95120,135 109.0%   
No. of employees `0002.71.2 237.3%   
Total wages/salary Rs m1,841703 261.8%   
Avg. sales/employee Rs Th4,590.95,176.2 88.7%   
Avg. wages/employee Rs Th673.4610.4 110.3%   
Avg. net profit/employee Rs Th592.1699.6 84.6%   
INCOME DATA
Net Sales Rs m12,5515,963 210.5%  
Other income Rs m54218 3,008.9%   
Total revenues Rs m13,0935,981 218.9%   
Gross profit Rs m2,0551,430 143.7%  
Depreciation Rs m412258 159.9%   
Interest Rs m96-26 -368.1%   
Profit before tax Rs m2,0881,216 171.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m469342 137.1%   
Profit after tax Rs m1,619806 200.9%  
Gross profit margin %16.424.0 68.3%  
Effective tax rate %22.528.1 79.8%   
Net profit margin %12.913.5 95.4%  
BALANCE SHEET DATA
Current assets Rs m7,7785,102 152.5%   
Current liabilities Rs m4,3582,385 182.7%   
Net working cap to sales %27.245.6 59.8%  
Current ratio x1.82.1 83.4%  
Inventory Days Days55150 36.4%  
Debtors Days Days80113 70.6%  
Net fixed assets Rs m5,7135,148 111.0%   
Share capital Rs m170158 107.2%   
"Free" reserves Rs m10,5476,556 160.9%   
Net worth Rs m10,9376,732 162.5%   
Long term debt Rs m0952 0.0%   
Total assets Rs m15,57410,388 149.9%  
Interest coverage x22.8-45.8 -49.9%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.80.6 140.4%   
Return on assets %11.07.5 146.6%  
Return on equity %14.812.0 123.6%  
Return on capital %20.014.6 136.7%  
Exports to sales %48.774.5 65.4%   
Imports to sales %7.124.8 28.6%   
Exports (fob) Rs m6,1154,441 137.7%   
Imports (cif) Rs m8891,477 60.2%   
Fx inflow Rs m6,1695,298 116.4%   
Fx outflow Rs m1,2851,772 72.5%   
Net fx Rs m4,8843,525 138.5%   
CASH FLOW
From Operations Rs m1,3971,274 109.6%  
From Investments Rs m-320-1,204 26.6%  
From Financial Activity Rs m-1,196-196 609.8%  
Net Cashflow Rs m-102-126 81.0%  

Share Holding

Indian Promoters % 55.4 0.0 -  
Foreign collaborators % 0.3 81.0 0.4%  
Indian inst/Mut Fund % 3.4 0.3 1,130.0%  
FIIs % 3.9 9.6 40.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 9.1 406.6%  
Shareholders   30,437 42,599 71.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   DR. DATSONS LABS  DISHMAN PHARMA  FULFORD INDIA  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Higher; Pharma Stocks Among Top Gainers(01:30 pm)

After opening the day in green, share markets in India witnessed choppy trades and are presently trading marginally above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Aug 22, 2017 02:29 PM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - WYETH LTD COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS